Skip to main content
. 2021 Nov 3;13(21):5523. doi: 10.3390/cancers13215523

Figure 1.

Figure 1

Workflow of development and validation. (A): Microaaray data and high- throughput qPCR workflow. (B): Gene selection using high- throughput qPCR. (C): Identification of differentially expressed gene between relapse and no-relapse groups using RNA sequencing.